* Viveve Medical Inc VIVE.OQ reported a quarterly adjusted
loss of 80 cents per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 51 cents per share.
* Revenue rose 11.2% to $1.45 million from a year ago; analysts
expected $1.33 million.
* Viveve Medical Inc's reported EPS for the quarter was a loss
of 80 cents.
* The mean earnings estimate of analysts had risen by
about 61.1% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Viveve Medical Inc shares had fallen by 21.6% this quarter and
lost 48.9% so far this year.
* The company reported a quarterly loss of $6.91 million.
* Wall Street's median 12-month price target for Viveve Medical
Inc is $9.63
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated May 14 at 08:02 a.m. GMT.
All figures in US dollars